Roth Capital Resumes BioLineRx (BLRX) at Buy
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Price: $3.54 +2.02%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Roth Capital resumed coverage on BioLineRx (NASDAQ: BLRX) with a Buy rating and a price target of $8.00.
For an analyst ratings summary and ratings history on BioLineRx click here. For more ratings news on BioLineRx click here.
Shares of BioLineRx closed at $2.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
- BofA Securities Resumes Williams-Sonoma (WSM) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
